T1	Participants 58 182	patients with type 2 diabetes mellitus and coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel
T2	Participants 334 385	patients receiving dual antiplatelet therapy (DAPT)
T3	Participants 435 458	patients receiving DAPT
T4	Participants 544 588	those presenting with diabetes mellitus (DM)
T5	Participants 834 896	DM patients with stable coronary artery disease receiving DAPT
T6	Participants 1378 1428	A total of 40 patients were available for analysis
T7	Participants 2107 2162	DM patients with coronary artery disease receiving DAPT
